Study of Glypican-3 in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

Serum Golgi protein 73 and glypican-3: early diagnostic biomarkers for hepatocellular carcinoma

Role Of Serum Glypican 3 As A Predictive Tool For Early Diagnosis Of Hepatocellular Carcinoma (HCC)

PREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA

Value of Glypican-3 as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma before and after Treatment. A Prospective Study

ROLE OF SERUM GLYPICAN-3 (GPC-3) IN EARLY DETECTION OF HEPATOCELLULAR CARCENOMA

Serum Level of Golgi Protein 73 as a Tumor Marker in Patients with Hepatocellular Carcinoma and Hepatitis C Virus-Related Liver Cirrhosis

Pentraxin 3 level as a Biomarker for Diagnosis of Hepatitis C Virus Related Hepatocellular Carcinoma

EXPRESSION OF GLYPICAN-3(GPC-3) AND 8-HYDROXYDEOXYGUANOSINE (8-OHDG) IN CHRONIC HEPATITIS C AND RELATIONSHIP WITH HEPATOCELLULAR CARCINOMA

Is Glypican-3 useful Diagnostic Marker that Distinguishes Hepatocellular Carcinoma from Liver Cirrhosis?